A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. (Q50575342)
Jump to navigation
Jump to search
scientific article published in October 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. |
scientific article published in October 2006 |
Statements
1 reference
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin. (English)
1 reference
1 reference
1 reference
A Ciancio
1 reference
A Picciotto
1 reference
C Giordanino
1 reference
A Smedile
1 reference
M Tabone
1 reference
A Manca
1 reference
G Marenco
1 reference
P Garbagnoli
1 reference
G Cariti
1 reference
G Calleri
1 reference
M Sartori
1 reference
S Cusumano
1 reference
A Grasso
1 reference
R Rizzi
1 reference
M Gallo
1 reference
M Basso
1 reference
M Anselmo
1 reference
G Percario
1 reference
M Rizzetto
1 reference
G Saracco
1 reference
1 October 2006
1 reference
24
1 reference
1079-1086
1 reference
7
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference